Exposure-response analysis of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukaemia and comparison with standard of care chemotherapy. - Kuchimanchi M; Zhu M; Clements JD; Doshi S (British journal of clinical pharmacology, 2019)